Innovation Pharmaceuticals - Stock

Innovation Pharmaceuticals Dividend 2024

Innovation Pharmaceuticals Dividend

0 USD

Innovation Pharmaceuticals Dividend yield

Ticker

IPIX

ISIN

US45782D1000

WKN

A2DTBJ

How much dividend does Innovation Pharmaceuticals 2024 pay?

According to the latest status from July 2024, Innovation Pharmaceuticals paid a total of 0 USD per share in dividends within the last 12 months. With the current Innovation Pharmaceuticals price of 0 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Innovation Pharmaceuticals Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Innovation Pharmaceuticals Dividend Safe?

Innovation Pharmaceuticals has been increasing the dividend for 0 years.

Over the past 10 years, Innovation Pharmaceuticals has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Innovation Pharmaceuticals's Dividend Distributions

Innovation Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Innovation Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Innovation Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Innovation Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Innovation Pharmaceuticals Aktienanalyse

What does Innovation Pharmaceuticals do?

Innovation Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development of novel therapeutics in various areas of medicine. Founded in 2007 as Cellceutix Corporation, the company was renamed Innovation Pharmaceuticals Inc. in 2016. The goal of Innovation Pharmaceuticals is to meet the needs of patients suffering from rare or severe diseases by developing innovative therapies. The focus is on combating inflammation, infections, and cancer. The company's business model is to guide compounds through the stages of clinical development and then license or sell them to large pharmaceutical companies. The different divisions of Innovation Pharmaceuticals are diverse and encompass dermatology, oncology, and infectious diseases, among others. The company has a pipeline of products currently in clinical trials or nearing entry into the clinical phase. One of Innovation Pharmaceuticals' leading products is Brilacidin, a synthetic peptide that can be used as a broad-spectrum antibiotic as well as a potential drug for the treatment of inflammation and cancer. Brilacidin has shown promising results in clinical studies and is currently being investigated in various indications. Another promising product of Innovation Pharmaceuticals is Kevetrin, a drug used for the treatment of cancer. Kevetrin is unique as it focuses on the p53 tumor suppression mechanism. Kevetrin is currently in the clinical phase of development, and Innovation Pharmaceuticals has begun to explore its use in various types of cancer. Innovation Pharmaceuticals also has an extensive portfolio of compounds and technologies in the preclinical stage. These compounds have the potential to create new therapeutic options for various diseases, including autoimmune diseases, chronic inflammatory diseases, and infectious diseases. In summary, Innovation Pharmaceuticals Inc. is a leading biopharmaceutical company focusing on the development of innovative therapeutics in various areas of medicine. The company has an impressive pipeline of products and technologies at various stages of development that have shown promising results. Innovation Pharmaceuticals has the potential to significantly improve the lives of patients with rare and severe diseases by developing novel therapies that are currently unavailable. Innovation Pharmaceuticals is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Innovation Pharmaceuticals stock

How much dividend does Innovation Pharmaceuticals pay?

Over the past 12 months, Innovation Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Innovation Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Innovation Pharmaceuticals?

The current dividend yield of Innovation Pharmaceuticals is .

When does Innovation Pharmaceuticals pay dividends?

Innovation Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Innovation Pharmaceuticals?

Innovation Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Innovation Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Innovation Pharmaceuticals located?

Innovation Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Innovation Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Innovation Pharmaceuticals from 7/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.

When did Innovation Pharmaceuticals pay the last dividend?

The last dividend was paid out on 7/4/2024.

What was the dividend of Innovation Pharmaceuticals in the year 2023?

In the year 2023, Innovation Pharmaceuticals distributed 0 USD as dividends.

In which currency does Innovation Pharmaceuticals pay out the dividend?

The dividends of Innovation Pharmaceuticals are distributed in USD.

Andere Kennzahlen von Innovation Pharmaceuticals

Our stock analysis for Innovation Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Innovation Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.